Title: Effect of acarbose on interleukin-4,-6, and-10 levels in patients with type 2 diabetes mellitus
Abstract: Sixty-six patients with type 2 diabetes mellitus,who did not take acarbose for the previous four weeks,were divided into acarbose group (A group,n =34) and non acarbose group (B group,n =32).33 healthy volunteers were selected as healthy controls (C group).Acarbose was prescribed 50 mg three times per day in A group and other hypoglycemic agents apart from acarbose were taken in B group.After four weeks of intervention,interleukin (IL)-4,IL-6,and IL-10 levels were determined with ELISA.The results showed that the baseline levels of IL-4 and IL-10 in C group were significantly higher than those in A and B groups,while the baseline level of IL-6 was lower (P<0.05).After four weeks of intervention,IL-6 level decreased more while IL-10 level increased more in group A than in group B (P<0.01).Although IL-4 levels increased in both group A and group B,the trend was not statistically different between two groups.The results suggest that acarbose therapy leads to favorable interleukin profile in patients with type 2 diabetes.
Key words:
Diabetes mellitus, type 2 ; Interleukin ; Acarbose
Publication Year: 2013
Publication Date: 2013-09-25
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot